Recommended Pages at roche.com
Roche - Media: News and Press Releases
roche.com — “Press releases, media archive with backgrounders, photo and video material. Subscribe to our events podcast and regular updates via RSS-feed.” View full resource at roche.com
Most Recently Shared on October 20, 2011 at 3:02 pm By:
Phase II study showed significant reduction in disease activity for multiple sclerosis patients for almost two years http://t.co/UGOrjk5Y
Roche - Roche named Dow Jones Sustainability Index leader in healthcare for third consecutive year
roche.com — “Roche - Roche named Dow Jones Sustainability Index leader in healthcare for third consecutive year” View full resource at roche.com
Most Recently Shared on September 8, 2011 at 11:53 am By:
Roche named Dow Jones Sustainability Index leader in healthcare for the 3rd year in a row! http://t.co/XCGEACM
Roche - Media: News and Press Releases
roche.com — “Press releases, media archive with backgrounders, photo and video material. Subscribe to our events podcast and regular updates via RSS-feed.” View full resource at roche.com
Most Recently Shared on September 1, 2011 at 8:58 am By:
For journalists: EU approval of medicine for first-line use in a genetically distinct type of #lungcancer http://t.co/wW6J6n8
Roche - Media Releases
roche.com — “Roche - Media Releases” View full resource at roche.com
Most Recently Shared on July 22, 2011 at 2:24 pm By:
Media Release: Roche drug gains positive CHMP opinion for 1st-line use in genetically distinct type of lung cancer http://cot.ag/nA9kJ6
Roche - Roche auf Kurs - Gewinnerwartung für 2011 erhöht
roche.com — “Roche - Roche auf Kurs - Gewinnerwartung für 2011 erhöht” View full resource at roche.com
Most Recently Shared on July 21, 2011 at 5:16 am By:
News: Roche auf Kurs – Gewinnerwartung für 2011 erhöht http://cot.ag/njJD2m #Roche #RocheIR
Roche - We innovate healthcare
roche.com — “Roche is systematically pursuing personalised medicine – it is an approach that is capable of increasing the safety, efficacy and cost-efficiency of treatment.” View full resource at roche.com
Most Recently Shared on July 5, 2011 at 7:35 am By:
Web update: Discover the Train of Hope - bringing healthcare to people in rural South Africa http://cot.ag/kNJ1Mm #CSR ^sk
Roche - Personalised Healthcare
roche.com — “Roche is systematically pursuing personalised medicine – it is an approach that is capable of increasing the safety, efficacy and cost-efficiency of treatment.” View full resource at roche.com
Most Recently Shared on June 1, 2011 at 3:53 pm By:
New website feature: How Roche is working to make personalized healthcare a reality: http://cot.ag/k86RRz #pharma ^sk
Roche - AgenoLAB Broadens Service Offering for Drug Development with Roche's RTCA Cardio Instrument
roche.com — “Roche - AgenoLAB Broadens Service Offering for Drug Development with Roche's RTCA Cardio Instrument” View full resource at roche.com
Most Recently Shared on May 12, 2011 at 12:17 pm By:
News: AgenoLAB Broadens Service Offering for Drug Development with Roche's RTCA Cardio Instrument http://dlvr.it/RSmHh
Roche - New drug applications submitted in the United States and Europe for vemurafenib in advanced skin cancer
roche.com — “Roche - New drug applications submitted in the United States and Europe for vemurafenib in advanced skin cancer” View full resource at roche.com
Most Recently Shared on May 11, 2011 at 5:07 am By:
News: New drug applications submitted in the United States and Europe for vemurafenib in advanced skin cancer http://dlvr.it/RJVnC
FDA Approves Roche's HPV Test for Identifying Women at Highest Risk for Cervical Cancer: Roche announced today t... http://bit.ly/hdMJ3H
roche.com — “FDA Approves Roche's HPV Test for Identifying Women at Highest Risk for Cervical Cancer: Roche announced today t... http://bit.ly/hdMJ3H” View full resource at roche.com
Most Recently Shared on April 20, 2011 at 9:27 pm By:
FDA Approves Roche's HPV Test for Identifying Women at Highest Risk for Cervical Cancer: Roche announced today t... http://bit.ly/hdMJ3H
Roche - Roche and NuGEN Technologies Develop Whole Transcriptome Profiling Solution for 454 Sequencing Systems
roche.com — “Roche - Roche and NuGEN Technologies Develop Whole Transcriptome Profiling Solution for 454 Sequencing Systems” View full resource at roche.com
Most Recently Shared on April 5, 2011 at 12:07 pm By:
News: Roche and NuGEN Technologies Develop Whole Transcriptome Profiling Solution for 454 Sequencing Systems http://dlvr.it/MX5xz
Roche - Pivotal Study Validates Roche's cobas HPV Test with HPV-16 and 18 Genotyping for Identifying Women at Highest Risk for Cervical Cancer
roche.com — “Roche - Pivotal Study Validates Roche's cobas HPV Test with HPV-16 and 18 Genotyping for Identifying Women at Highest Risk for Cervical Cancer” View full resource at roche.com
Most Recently Shared on February 25, 2011 at 7:48 am By:
Pivotal Study Validates Roche’s cobas® HPV Test with HPV-16 and 18 Genotyping for Identifying Women with... http://cot.ag/eetN8C #RocheIR
Roche - We innovate healthcare
roche.com — “Roche is systematically pursuing personalised medicine -- it is an approach that is capable of increasing the safety, efficacy and cost-efficiency of treatment.” View full resource at roche.com
Most Recently Shared on February 2, 2011 at 9:28 am By:
Diagnostics COO Dan O'Day: "We are demonstrating the value of diagnostics and improving patient care" - http://bit.ly/hmyJRm #RocheIR
Roche - Early successful readout of Tarceva study in a distinct form of lung cancer
roche.com — “Roche - Early successful readout of Tarceva study in a distinct form of lung cancer” View full resource at roche.com
Most Recently Shared on January 30, 2011 at 7:53 pm By:
Tarceva for lung cancer PhaseIII (Roche) http://www.roche.com/media/media_releases/med-cor-2011-01-28.htm
Roche - ACTEMRA/RoACTEMRA (tocilizumab) supplemental marketing authorizations submitted in the US and Europe for the treatment of systemic Juvenile Idiopathic Arthritis
roche.com — “Roche - ACTEMRA/RoACTEMRA (tocilizumab) supplemental marketing authorizations submitted in the US and Europe for the treatment of systemic Juvenile Idiopathic Arthritis” View full resource at roche.com
Most Recently Shared on October 18, 2010 at 7:22 am By:
ACTEMRA/RoACTEMRA (tocilizumab) supplemental marketing authorizations submitted in the US and Europe http://bit.ly/d07HsG #RocheIR
